Nirmatrelvir-ritonavir for the treatment of COVID-19 patients: A systematic review and meta-analysis

被引：32
|
作者：
Cheema, Huzaifa A. A. [1 ]
Jafar, Uzair [1 ]
Sohail, Aruba [2 ]
Shahid, Abia [1 ]
Sahra, Syeda [3 ]
Ehsan, Muhammad [1 ]
Athar, Farwa [1 ]
Shah, Jaffer F. [4 ]
Sah, Ranjit [5 ]
机构：
[1] King Edward Med Univ, Dept Med, Div Infect Dis, Lahore 54000, Punjab, Pakistan
[2] Dow Univ Hlth Sci, Dept Med, Karachi, Pakistan
[3] Univ Oklahoma, Dept Infect Dis, Hlth Sci Ctr, Oklahoma City, OK USA
[4] New York State Dept Hlth, Albany, NY USA
[5] Tribhuvan Univ, Inst Med, Teaching Hosp, Kathmandu, Nepal
来源：
JOURNAL OF MEDICAL VIROLOGY | 2023年 / 95卷 / 02期
关键词：
D O I：
10.1002/jmv.28471
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页数：6
相关论文
共 50 条
  • [1] Nirmatrelvir-ritonavir compared with other antiviral drugs for the treatment of COVID-19 patients: A systematic review and meta-analysis
    Tian, Fangyuan
    Chen, Zhaoyan
    Feng, Qiyi
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2023, 95 (04)
  • [2] Nirmatrelvir-ritonavir for COVID-19
    McDonald, Emily G.
    Lee, Todd C.
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2022, 194 (06) : E218 - E218
  • [3] Nirmatrelvir-ritonavir (Paxlovid®), a treatment for Covid-19
    Buxeraud, Jacques
    Faure, Sebastien
    Fougere, Edouard
    [J]. ACTUALITES PHARMACEUTIQUES, 2020, 61 (617): : 10 - 12
  • [4] Nirmatrelvir-ritonavir for nonhospitalized patients with COVID-19
    LeBras, Marlys
    Crawley, Alex
    Legge, Marc
    Takaya, Satchan
    Lee, Stephen
    Regier, Loren
    [J]. CANADIAN FAMILY PHYSICIAN, 2023, 69 (08) : 546 - 549
  • [5] Comparative efficacy and safety of nirmatrelvir/ritonavir and molnupiravir for COVID-19: A systematic review and meta-analysis
    Amani, Bahman
    Akbarzadeh, Arash
    Amani, Behnam
    Shabestan, Rouhollah
    Khorramnia, Saeed
    Navidi, Zia
    Rajabkhah, Kourosh
    Kardanmoghadam, Vida
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2023, 95 (06)
  • [6] Effectiveness of Molnupiravir and Nirmatrelvir-Ritonavir in Hospitalized Patients With COVID-19
    Focosi, Daniele
    Nicastri, Emanuele
    [J]. ANNALS OF INTERNAL MEDICINE, 2023, 176 (10)
  • [7] Effectiveness of Molnupiravir and Nirmatrelvir-Ritonavir in CKD Patients With COVID-19
    Cheng, Franco Wing Tak
    Yan, Vincent Ka Chun
    Wan, Eric Yuk Fai
    Chui, Celine Sze Ling
    Lai, Francisco Tsz Tsun
    Wong, Carlos King Ho
    Li, Xue
    Zhang, Irene Ran
    Tang, Sydney Chi Wai
    Wong, Ian Chi Kei
    Chan, Esther Wai Yin
    [J]. KIDNEY INTERNATIONAL REPORTS, 2024, 9 (05): : 1244 - 1253
  • [8] Effectiveness of nirmatrelvir-ritonavir on severe outcomes of COVID-19: A meta-regression analysis
    Chen, I-Wen
    Yu, Ting-Sian
    Lin, Chien-Hung
    Hung, Kuo-Chuan
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2024, 96 (06)
  • [9] Effectiveness of nirmatrelvir-ritonavir on severe outcomes of COVID-19 in the era of vaccination and Omicron: An updated meta-analysis
    Ombelet, Sien
    Castanares-Zapatero, Diego
    Desimpel, Fabian
    Hulstaert, Frank
    Stordeur, Sabine
    Roberfroid, Dominique
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2024, 96 (02)
  • [10] Nirmatrelvir-Ritonavir and Viral Load Rebound in Covid-19
    Anderson, Annaliesa S.
    Caubel, Patrick
    Rusnak, James M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (11): : 1047 - 1049
12345